These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21045705)

  • 1. Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms.
    Parsons JK
    Curr Opin Urol; 2011 Jan; 21(1):1-4. PubMed ID: 21045705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of exercise and the risk of benign prostatic hyperplasia.
    Sea J; Poon KS; McVary KT
    Phys Sportsmed; 2009 Dec; 37(4):75-83. PubMed ID: 20048544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An algorithm for medical management in male lower urinary tract symptoms.
    Djavan B; Margreiter M; Dianat SS
    Curr Opin Urol; 2011 Jan; 21(1):5-12. PubMed ID: 21045704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.
    Parsons JK
    J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.
    Rosen RC
    Curr Opin Urol; 2006 Jan; 16(1):11-9. PubMed ID: 16385195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion.
    Lowe FC; Batista J; Berges R; Chartier-Kastler E; Conti G; Desgrandchamps F; Dreikorn K; O'Leary M; Perez M; Speakman M; Trachtenberg J; Tubaro A; Meesen B; Smets L; Stoevelaar H
    Prostate Cancer Prostatic Dis; 2005; 8(3):206-9. PubMed ID: 15953934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: who are the high-risk patients and what are the best treatment options?
    Robert G; Descazeaud A; de la Taille A
    Curr Opin Urol; 2011 Jan; 21(1):42-8. PubMed ID: 21045706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know?
    Sarma AV; Parsons JK; McVary K; Wei JT
    J Urol; 2009 Dec; 182(6 Suppl):S32-7. PubMed ID: 19846144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia.
    Roehrborn CG
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S19-26. PubMed ID: 19002120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins.
    Rohrmann S; Fallin MD; Page WF; Reed T; Partin AW; Walsh PC; Platz EA
    Epidemiology; 2006 Jul; 17(4):419-27. PubMed ID: 16699472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)].
    Rosen R; Altwein J; Boyle P; Kirby RS; Lukacs B; Meuleman E; O'Leary MP; Puppo P; Chris R; Giuliano F
    Prog Urol; 2004 Jun; 14(3):332-44. PubMed ID: 15373175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia.
    Parsons JK; Im R
    J Urol; 2009 Oct; 182(4):1463-8. PubMed ID: 19683313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum neurotoxin A for male lower urinary tract symptoms.
    Chartier-Kastler E; Mehnert U; Denys P; Giuliano F
    Curr Opin Urol; 2011 Jan; 21(1):13-21. PubMed ID: 21099691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise.
    Speakman M; Batista J; Berges R; Chartier-Kastler E; Conti G; Desgrandchamps F; Dreikorn K; Lowe F; O'Leary M; Perez M; Trachtenberg J; Tubaro A; Meesen B; Smets L; Stoevelaar H
    Prostate Cancer Prostatic Dis; 2005; 8(4):369-74. PubMed ID: 16130013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrition and benign prostatic hyperplasia.
    Espinosa G
    Curr Opin Urol; 2013 Jan; 23(1):38-41. PubMed ID: 23202286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.
    Lowe FC
    Clin Ther; 2004 Nov; 26(11):1701-13. PubMed ID: 15639685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia: does lifestyle play a role?
    Barnard RJ; Aronson WJ
    Phys Sportsmed; 2009 Dec; 37(4):141-6. PubMed ID: 20048551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia.
    Favilla V; Cimino S; Castelli T; Madonia M; Barbagallo I; Morgia G
    BJU Int; 2010 Dec; 106(11):1700-3. PubMed ID: 20575982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.